Page last updated: 2024-11-05

calusterone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Calusterone is a synthetic androgen that was initially developed for the treatment of prostate cancer. Its synthesis involves modifications to testosterone, resulting in a compound with a longer half-life and a greater affinity for androgen receptors. Calusterone has been shown to have a variety of effects, including the suppression of testosterone production, the induction of apoptosis in prostate cancer cells, and the inhibition of tumor growth. While initially studied as a potential treatment for prostate cancer, research on calusterone has expanded to explore its potential in other areas, such as the treatment of acne and hair loss. Further research is ongoing to investigate its potential benefits and risks. '

calusterone: was MH 1975-92 (see under METHYLTESTOSTERONE 1975-90); use METHYLTESTOSTERONE to search CALUSTERONE 1975-92 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID28204
CHEMBL ID455706
CHEBI ID135356
SCHEMBL ID4509
MeSH IDM0197664

Synonyms (71)

Synonym
u-22,550
17-.beta.-hydroxy-7-.beta.-17-dimethyl androst-4-en-3-one
u 22550
7.beta.,17.alpha.-dimethyltestosterone
7-.beta.-17-dimethyltestosterone
wln: l e5 b666 ov mutj a1 e1 fq f1 k1
androst-4-en-3-one,17.alpha.-dimethyl-17.beta.-hydroxy-
7.beta.,17.alpha.-dimethyl testosterone
methosarb
androst-4-en-3-one,17-dimethyl-, (7.beta.,17.beta.)-
nsc88536
nsc-88536
17021-26-0
7-.beta.-17-.alpha.-dimethyltestosterone
hsdb 3210
androst-4-en-3-one, 17-beta-hydroxy-7-beta,17-dimethyl-
androst-4-en-3-one, 17-hydroxy-7,17-dimethyl-, (7-beta,17-beta)-
androst-4-en-3-one, 7beta,17alpha-dimethyl-17beta-hydroxy-
androst-4-en-3-one, 17beta-hydroxy-7beta,17-dimethyl-
calusteronum [inn-latin]
17-beta-hydroxy-7-beta-17-dimethyl androst-4-en-3-one
androst-4-en-3-one, 7-beta,17-alpha-dimethyl-17-beta-hydroxy-
brn 3212336
calusterona [inn-spanish]
calusterone [usan:inn]
androst-4-en-3-one, 17-hydroxy-7,17-dimethyl-, (7beta,17beta)-
(7beta,8xi,17beta)-17-hydroxy-7,17-dimethylandrost-4-en-3-one
D03338
calusterone (usan/inn)
dimethyltestosterone
calusterone
17beta-hydroxy-7beta,17-dimethylandrost-4-en-3-one
7beta,17alpha-dimethyltestosterone
7-beta,17-alpha-dimethyl testosterone
DB01564
7-beta,17-dimethyltestosterone
7beta,17-dimethyltestosterone
17beta-hydroxy-7beta,17alpha-dimethylandrost-4-ene-3-one
17-beta-hydroxy-7-beta,17-alpha-dimethylandrost-4-ene-3-one
CHEBI:135356
u-22550
CHEMBL455706
(7s,8r,9s,10r,13s,14s,17s)-17-hydroxy-7,10,13,17-tetramethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-3-one
4-08-00-01029 (beilstein handbook reference)
unii-0678g6q58a
calusterona
calusteronum
7beta,17alpha-dimethyl-17betahydroxyandrost-4-en-3-one
0678g6q58a ,
SCHEMBL4509
7.beta.,17.alpha.-dimethyl-17.beta.-hydroxyandrost-4-en-3-one
calusterone [usan]
calusterone [who-dd]
calusterone [mi]
calusterone [hsdb]
calusterone [inn]
calusterone [mart.]
DTXSID0022723
(1s,2r,9s,10r,11s,14s,15s)-14-hydroxy-2,9,14,15-tetramethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one
17beta-hydroxy-7beta-17alpha-dimethylandrost-4-ene-3-one
7beta-dimethyltestosterone
17-dimethyl-17beta-hydroxy-7beta-androst-4-en-3-one
(7b,17b)-17-hydroxy-7,17-dimethyl-androst-4-en-3-one
7beta,17beta-dimethyltestosterone
17beta-hydroxy-7beta-17-dimethylandrost-4-en-3-one
17b-hydroxy-7b,17-dimethyl-androst-4-en-3-one
17b-hydroxy-7b,17-dimethylandrost-4-en-3-one
17beta-dimethyl testosterone
7-beta-17-alpha-dimethyltestosterone
4-androsten-7beta,17alpha-dimethyl-17beta-ol-3-one
Q14201166
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
androgenA sex hormone that stimulates or controls the development and maintenance of masculine characteristics in vertebrates by binding to androgen receptors.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
3-hydroxy steroidAny hydroxy steroid carrying a hydroxy group at position 3.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID409942Inhibition of human recombinant MAOA by fluorimetric method2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID1130876Toxicity in rat 13762 cells allografted in Fischer 344 rat assessed as ratio of final body weight to initial body weight at 100 mg/kg, ip qd for 20 days1979Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
Syntheses and biological activities of 7 beta-methyl steroids.
AID1130882Effect on pituitary weight in rat 13762 cells allografted Fischer 344 rat at 100 mg/kg, ip qd for 20 days relative to control1979Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
Syntheses and biological activities of 7 beta-methyl steroids.
AID1130880Effect on adrenal weight in rat 13762 cells allografted Fischer 344 rat at 100 mg/kg, ip qd for 20 days relative to control1979Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
Syntheses and biological activities of 7 beta-methyl steroids.
AID1130881Effect on thymus weight in rat 13762 cells allografted Fischer 344 rat at 100 mg/kg, ip qd for 20 days relative to control1979Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
Syntheses and biological activities of 7 beta-methyl steroids.
AID1130877Effect on ovarian weight in rat 13762 cells allografted Fischer 344 rat at 100 mg/kg, ip qd for 20 days relative to control1979Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
Syntheses and biological activities of 7 beta-methyl steroids.
AID1130866Antitumor activity against rat 13762 cells allografted in Fischer 344 rat assessed as tumor weight at 100 mg/kg, ip qd for 20 days relative to control1979Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
Syntheses and biological activities of 7 beta-methyl steroids.
AID1130875Antitumor activity against rat 13762 cells allografted in Fischer 344 rat assessed as host survival at 100 mg/kg, ip qd for 20 days1979Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
Syntheses and biological activities of 7 beta-methyl steroids.
AID1130878Effect on uterine weight in rat 13762 cells allografted Fischer 344 rat at 100 mg/kg, ip qd for 20 days relative to control1979Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
Syntheses and biological activities of 7 beta-methyl steroids.
AID1130879Effect on spleen weight in rat 13762 cells allografted Fischer 344 rat at 100 mg/kg, ip qd for 20 days relative to control1979Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
Syntheses and biological activities of 7 beta-methyl steroids.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (60.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.06 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.21 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]